|Articles|September 15, 2002
- BioPharm International-09-01-2002
- Volume 15
- Issue 9
If a Tree Fell in the Forest
Author(s)Jim Miller
by Jim Miller, Bio/Pharmaceutical Outsourcing Report If a CRO or contract manufacturer was outperforming others in the industry, would anybody notice?
Advertisement
Articles in this issue
over 23 years ago
Reexamining the Set It and Forget It Approachover 23 years ago
Security in the Corporate Homelandover 23 years ago
Integrating New Technology into Blood Plasma Fractionationover 23 years ago
Attack Mounts on Pharmaceutical PricesNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5
